Mevaseret-Zion, Israel

Joseph Frucht-Perry

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2002.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:

goldMedal1 out of 834,453 
Other
 patents

Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Joseph Frucht-Perry: Innovator in Drug Administration Technology

Introduction

Joseph Frucht-Perry is a notable inventor based in Mevasseret Zion, IL. He has made significant contributions to the field of drug administration technology. His innovative approach focuses on the iontophoretic delivery of drugs, particularly for ocular applications.

Latest Patents

Joseph Frucht-Perry holds a patent for a device designed for the iontophoretic administration of drugs. This device is specifically tailored for administering charged drugs to the eye. It features an applicator with a receiving portion that holds a hydrogel carrier loaded with the drug. Additionally, the device includes an electric current generating element that produces currents not exceeding 1000 µAmp. A timing element ensures that these currents do not last more than 120 seconds.

Career Highlights

Throughout his career, Joseph Frucht-Perry has demonstrated a commitment to advancing medical technology. His work has focused on improving the efficacy and safety of drug delivery systems. With a patent portfolio that includes one patent, he has established himself as a key figure in his field.

Collaborations

Joseph has collaborated with esteemed colleagues such as Abraham Domb and Mervyn Shapiro. These partnerships have contributed to the development and refinement of his innovative technologies.

Conclusion

Joseph Frucht-Perry's contributions to drug administration technology highlight his role as an inventor dedicated to improving healthcare solutions. His patented device represents a significant advancement in the field, showcasing his innovative spirit and commitment to medical progress.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…